FDA Inspection 1218308 — Kentucky Blood Center Inc
The FDA completed an inspection of Kentucky Blood Center Inc on Sep 18, 2023 in Lexington, KY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Sep 18, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Lexington, KY (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 9271 | 21 CFR 610.41 | Donor Deferral - reentry |